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Abstract Mitochondria are an essential source of ATP
for cellular function, but when damaged, mitochondria
generate a plethora of stress signals, which lead to cellular
dysfunction and eventually programmed cell death. Thus, a
major component of maintaining cellular homeostasis is
the recognition and removal of dysfunctional mitochondria
through autophagy-mediated degradation, i.e., mitophagy.
Mitophagy further constitutes a developmental program,
and undergoes a high degree of crosstalk with apoptosis.
Reduced mitochondrial quality control is linked to disease
pathogenesis, suggesting the importance of process eluci-
dation as a clinical target. Recent work has revealed
multiple mitophagy programs that operate independently or
undergo crosstalk, and require modulated autophagy
receptor activities at outer membranes of mitochondria.
Here, we review these mitophagy programs, focusing on
pathway mechanisms which recognize and target mito-
chondria for sequestration by autophagosomes, as well as
mechanisms controlling pathway activities. Furthermore,
we provide an introduction to the currently available
methods for detecting mitophagy.
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Abbreviations
Atg Autophagy-related protein
GABARAP Gamma-aminobutyric acid receptor-
associated protein
HIF1 Hypoxia-inducible factor 1
IMM Inner mitochondrial membrane
LC3 Microtubule-associated protein light chain 3
LIR LC3-interacting region
mTOR Mammalian target of rapamycin
OMM Outer mitochondrial membrane
PE Phosphatidylethanolamine
ROS Reactive oxygen species
TCA Tricarboxylic acid
TFEB Transcription factor EB
Introduction
Mitochondria are organelles surrounded by a double
membrane, comprised of the outer mitochondrial mem-
brane (OMM) and the inner mitochondrial membrane
(IMM) (Fig. 1a). Mitochondria are abundant in most cell
types, and occupy approximately 10–40 % of cellular
volume [1]. For example, the mitochondrial population
accounts for approximately 30 % of the cellular volume of
HeLa cells, and for 22–37 % of the cardiac cell volume [2].
Furthermore, depending on cell types, mitochondrial mor-
phologies [3] and numbers vary considerably. For example,
cardiac myocytes contain several thousand morphologi-
cally similar mitochondria [4], while neurons carry several
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hundred dynamic and morphologically heterogeneous
mitochondria [5]. The cellular functions of mitochondria
are multifaceted and encompass the production of the
bioenergetic carrier adenosine triphosphate (ATP), partic-
ipation in reactive oxygen species (ROS) (Fig. 1b) [6] and
calcium [7] signaling, metabolite synthesis, programmed
cell death [8], and tumorigenesis [9, 10].
Mitochondrial bioenergetic function involves the oxidation
of acetyl-CoA in the tricarboxylic acid (TCA) cycle to gen-
erate NADH and FADH2, which transfer electrons to the
electron transport chain to produce an electrochemical
gradient across the IMM that is used to produce ATP [11]
(Fig. 1c). Ultimately, electrons are transferred to molecular
oxygen (O2), reducing it to H2O. The coupling of these pro-
cesses is termed mitochondrial oxidative phosphorylation, aka
cellular respiration. Due to leakage of electrons at complex I
or complex III of the electron transport chain, O2 can be
incompletely reduced and generate the superoxide anion, the
precursor to most ROS [12]. Low levels of ROS play physi-
ological roles [6], while high and/or prolonged elevations of
ROS can oxidize proteins, lipids, and nucleic acids, leading to
cellular dysfunction and programmed cell death [13].
Damaged mitochondria can signal programmed cell
death [8], inflammation and aging [14]. Enhanced levels of
damaged mitochondria aggravate many diseases, and par-
ticipate in disease pathogenesis [15–17]. To maintain
homeostasis of the mitochondrial population, cells rely on
autophagy, a quality control process by which components
of the cytoplasm are sequestered and delivered to lyso-
somes for degradation [18]. Dysfunctional mitochondria
can be recognized and targeted for degradation by a
specific mode of autophagy, termed mitophagy. Experi-
mentally this has been evidenced in cell culture and in vivo
models, whereby genetic knockout of autophagy proteins
results in increased mitochondrial mass, and increased
numbers of dysfunctional mitochondria and ROS levels
[19, 20]. While targeting of mitochondria to lysosomes was
detected over 50 years ago [21], recent years have yielded
rapid progress in elucidating mechanisms which underlie
distinct mitophagy programs. In this review, we focus on
the mechanisms which orchestrate the targeting of the
autophagic machinery to the OMM, discuss physiological
roles of mitophagy, and present an overview of methods
used to evidence mitophagic activity.
Mitochondrial dynamics prime mitochondria
for mitophagy
The machinery regulating mitochondrial morphology
dynamics is highly integrated with mitophagy initiation.
Mitochondrial fission, i.e., division, is mediated by the
GTPase dynamin-related protein 1 (Drp1), whereas fusion
involves three GTPases; mitofusins 1 and 2 (Mfn1 and
Mfn2) mediate outer membrane fusion and optic atrophy 1
(OPA1) mediates inner membrane fusion (Fig. 2) [22].
Upon fission, mitochondria can be segregated into polar-
ized and depolarized daughter mitochondria. While
polarized daughter mitochondria can undergo fusion, con-
sistent with the polarization requirement for fusion [23],
depolarized mitochondria are targeted by mitophagy [24].
Consistent with this observation, inhibiting the fission
machinery or enhancing mitochondrial fusion were both
shown to decrease mitophagy [24], while enhancing fission
Fig. 1 Mitochondrial function and dysfunction. a A mitochondrion is
enclosed by two membranes, the outer mitochondrial membrane
(OMM) and inner mitochondrial membrane (IMM). The mitochon-
drial compartment between the OMM and IMM is referred to as the
intermembrane space (IMS). The respiratory chain (electron transport
chain, ETC), which is composed of complexes I–V and localized in
the IMM, drives ATP synthesis in the mitochondrial matrix. b ROS
are implicated in both physiological and pathophysiological signaling.
c Electrons from the tricarboxylic acid (TCA) cycle substrates are
transferred through the respiratory chain complexes (along the yellow
arrows), driving the extrusion of protons (?) from the matrix, thereby
generating the proton motive force. Proton flow through the ATP
synthase (complex V) drives ATP production. Oxygen (O2) serves as
the terminal electron acceptor at complex IV, forming H2O. At
complexes I and/or III electron leak can produce the reactive oxygen
species (ROS) superoxide anion (O2
-
˙ )
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promotes mitophagy [25]. Furthermore, during nutrient
starvation-induced autophagy, protein kinase A (PKA)-
mediated phosphorylation of Drp1 inactivates fission
events, driving the mitochondrial network to an increased
fusion state, as a mitophagy inhibition mechanism [26, 27].
Notably, a recent in vivo study has revealed a higher
level of complexity. In a conditional Drp1 deletion model
in mouse heart, Drp1 knockout increased mitophagy, and
promoted dilated cardiomyopathy associated with
increased levels of necrotic cell death [28]. Conversely,
conditional Mfn1/2 knockout resulted in accumulated
dysfunctional mitochondria, lack of mitophagy, and
hypertrophy without inducing cell death. These findings
not only confirm that mitochondrial dynamics are an
essential component of mitophagy, but also expand our
understanding past cell culture-based experiments,
demonstrating that in vivo the loss of mitochondrial quality
control via mitochondrial morphology dynamics is able to
engage compensating mitophagy pathways.
Autophagy induction, maturation,
and degradation
Macroautophagy (in this review referred to as autophagy) is a
catabolic process that in the presence of growth factors and
amino acids are negatively regulated by anabolic mTOR
signaling. As such, autophagy is repressed under nutrient-
rich conditions, and activated under conditions of decreased
ATP and nutrients [29]. Upon its induction, the autophagic
machinery coordinates the formation and expansion of the
so-called phagophore, which encloses cellular proteins and
organelles within a double-membraned organelle, the
autophagosome. These membrane events are controlled by
autophagy-related (Atg) proteins [30]. Autophagosomal
membranes likely originate from the endoplasmic reticulum,
and may include membrane contents originating from
mitochondria, plasma membrane, Golgi, and endosomes
[31]. Once formed, the autophagosome fuses with
endolysosomes to mature into the autolysosome, whereupon
lysosomal hydrolases degrade the autophagosomal inner
membrane and its contents [32]. The fusion of autophago-
somes with endolysosomes is a highly regulated process
(Fig. 3a), and dependent on the GTPase Rab7, which regu-
lates endolysosomal trafficking [33, 34]. Recent findings
have shown that maturation is regulated by adaptor proteins
which bind autophagosomes and endolysosomes to promote
fusion and maturation [35, 36]. The HOPS (homotypic
fusion and vacuole protein sorting) tethering complex is
responsible for autolysosome formation [37]. HOPS com-
plexes with PLEKHM1 (pleckstrin homology domain
containing protein family member 1), which binds Rab7, and
can interact with autophagosomes to promote fusion
between endolysosomes and autophagosomes [36]. Subse-
quent membrane fusion events are carried out by SNARE
(soluble N-ethylmaleimide-sensitive factor attachment pro-
tein receptor) proteins; The SNARE Syntaxin 17 binds with
the HOPS complex [37], and its interaction with the
endolysosomal SNARE VAMP8 mediates fusion of
autophagosomes with endolysosomes [38].
Fig. 2 Mitochondrial dynamics are linked to mitophagy. The
GTPases Mitofusin 1 (Mfn1) and Mitofusin 2 (Mfn2) mediate
OMM fusion, and the GTPase OPA1 (Optic atrophy 1) mediates IMM
fusion. Mitochondrial fragmentation requires the translocation of the
GTPase Drp1. Normally cytosolic, Drp1 is recruited to mitochondria
via OMM-bound receptor proteins Fis1, Mff, MID49, and MID51.
Protein kinase A (PKA)-mediated phosphorylation of Drp1 at serine
656 inhibits its activity, resulting in hyperfused mitochondrial
networks, while dephosphorylation by the phosphatase calcineurin
activates Drp1. Active Drp1 constricts and fragments mitochondria.
Drp1-driven mitochondrial fragmentation is a critical quality control
event upstream of mitophagy
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Post-translational modification of Atg8 family
proteins during autophagosome formation
A key process in the formation of the phagophore is the
conjugation of Atg8 (autophagy-related protein 8) family
protein members to phosphatidylethanolamine (PE) [39, 40],
an integral membrane component of the autophagosome. In
mammals, Atg8 proteins can be divided into LC3
(microtubule-associated protein light chain 3) and
GABARAP (gamma-aminobutyric acid receptor-associated
protein) subfamilies. The LC3 family includes LC3A,
LC3B, LC3B2, and LC3C, and the GABARAP family
includes GABARAP, GABARAP-L1, GABARAP-L2/
GATE-16, and GABARAP-L3. In the following text,
mammalian Atg8 family proteins in general are referred to as
LC3. All LC3 family members are integrated into
autophagosomes via a C-terminal glycine, covalently con-
jugated to PE. LC3 conjugation involves two ubiquitin-like
reactions (Fig. 3b). The Atg4 cysteine protease first cleaves
pro-LC3 at the C-terminus to expose a glycine residue,
forming LC3-I. Upon autophagy induction E1 (Atg7) and E2
(Atg3) system conjugates PE to LC3-I, forming LC3-II.
Atg12 is conjugated to Atg5 by Atg7 (E1-like) and Atg10
(E2). Atg7 and Atg10 conjugate Atg5 and Atg12, which then
forms a complex with Atg16. The Atg5/12/16 complex acts
as an E3 ligase, promoting PE conjugation to LC3 [41].
Upstream, the participation of LC3 proteins in autop-
hagy is regulated by phosphorylation. For instance,
integration of LC3B into autophagosomal membranes is
suppressed by phosphorylation at serine 12 by protein
kinase A (PKA) [42], and STK3/STK4-mediated phos-
phorylation of LC3B at threonine 50 is needed for efficient
autolysosome formation [43] (Figs. 3a, 4a).
While the functional diversity of LC3 proteins has not
been entirely established, it has been proposed that LC3
subfamily proteins participate in autophagosomal mem-
brane elongation, while GABARAP subfamily proteins
mediate autophagosome maturation [44]. Importantly, LC3
and GABARAP proteins can both serve as binding partners
for autophagy receptors, thereby underlying specific modes
of autophagy, and permitting autophagy control of diverse
cell signaling events, including the antioxidant response
[45], pathogen response [46], as well as mitophagy [47].
LC3 interacting region (LIR) motifs as a basis
for specific autophagy
LC3 proteins contain a conserved hydrophobic region,
comprised the so-called W and L pockets [48, 49], which
docks via hydrophobic interactions with a motif, termed
LC3-interacting region (LIR), contained within autophagy
receptors [47, 48, 50, 51] (Fig. 4a, b). This LIR motif, also
referred to as AIM (Atg8-family-interacting motif) or LC3
recognition sequence (LRS), comprises a core consensus
sequence of an aromatic residue followed by a hydrophobic
residue [W/F/Y]xx[L/I/V] [47]. This sequence is preceded
by negatively charged residues, which are critical for the
interaction with positively charged residues on LC3 pro-
teins. Moreover, serine/threonine residues within this LIR
preceding region were shown to be fundamental for the
Fig. 3 Autophagosome formation and degradation. a Autophagy
involves phagophore-nucleated autophagosome formation, fusion
with endolysosomes to form the autolysosome, and subsequent
degradation of the autophagosome and its contents by lysosomal
hydrolases. Mammalian Atg8 proteins include proteins of the LC3
subfamily, which participate in phagophore elongation, and of the
GABARAP subfamily, which coordinate closure of autophagosome.
Proper LC3 function is positively and negatively regulated through
phosphorylation. Fusion between autophagosome and endolysosomes
is coordinated by Pleckhm1, which at the endolysosome binds Rab7
and the HOPS complex, and at the autophagosome binds LC3 and the
HOPS complex. The SNARE member Syntaxin17 (STX17) binds
autophagosomes through interaction with the endolysosomal SNARE
VAMP8, thereby mediating autophagosomal-lysosomal membrane
fusion. Autophagosomes and content are then degraded by lysosomal
hydrolases. b Cytosolic microtubule-associated protein light chain 3
(LC3)-I is conjugated to phosphatidylethanolamine (PE) to form
lipidated LC3-II (LC3-PE), an integral membrane component of the
autophagosome and binding partner for autophagy receptors. Two
ubiquitin-like conjugation reactions coordinate LC3 lipidation. (1)
E1-like and E2-like Atg7 and Atg10 conjugate Atg12 to Atg5, which
then complex with Atg16. (2) Pro-LC3 is cleaved at the C-terminus
by Atg4, forming LC3-I, which is activated by E1-like Atg7. Through
the E2-like Atg3 and E3-like Atg12-Atg5-Atg16 complex, LC3 is
lipidated with PE
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regulation of autophagy receptor activity through phos-
phorylation [46, 52, 53]. So far, it has not been determined
if LC3 phosphorylation similarly alters its capacity to bind
with autophagy receptors.
During mitophagy, OMM-localized autophagy receptors
(mitophagy receptors) attach autophagosomes to the OMM
via their LIR motif. To date, eight mechanistically distinct
mitophagy receptors have been characterized (Fig. 4c), and
can be grouped according to the manner in which they
target mitochondria (Fig. 4d). One group of mitophagy
receptors contains a ubiquitin-binding domain which
localizes them to Parkin-ubiquitylated mitochondria,
including p62/SQSTM1, NBR1, and optineurin [54–57]. In
addition, mitochondrial-localized Parkin binds AMBRA1
to localize it at the OMM [58, 59]. The second group of
mitophagy receptors is made up of Bnip3 [52, 60, 61], its
homologue Bnip3L/Nix [62–64], FUNDC1 [53], and
Bcl2L13 [65]. These mitophagy receptors contain trans-
membrane domains and upon expression constitutively
localize to the OMM [53, 66–68].
Below we discuss protein mitophagy receptor systems
which have been mechanistically elucidated, namely the
PINK1/Parkin system, and transmembrane-containing
mitophagy receptors. We further discuss the lipids cer-
amide and cardiolipin, which when localized to the OMM
can directly bind LC3 and engage mitophagy [69, 70].
Fig. 4 The LC3-interacting region (LIR) motif as a mechanistic basis
for mitophagy. a LC3B structure (PDB 1UGM) [179], analyzed using
Chimera [180]. Upper panel ribbon structure diagram indicating a-
helices and b-sheets. LC3 proteins contain two N-terminal a-helices
and a ubiquitin-like core formed from b strands. Hydrophobic pockets
between b2 and a2 form the W-site, and between b2 and a3 form the
L-site. Middle panel surface representation indicates topology of W-
and L-sites (adapted from [49]), phosphorylated residues at S12 and
T50, and putative binding sites for cardiolipin (R10 and R11) and
ceramide (I35 and F52). Lower panel, N-terminal sequence align-
ments of LC3 homologues. Tcoffee alignment [181] of human LC3
member N-terminal regions using Jalview [182]. Blue shading
indicates percentage identity, positively charged R, K and H residues,
aligning to LC3B R10 and R11, are indicated in red. b The LIR motif,
also known as Atg8 family-interacting motif (AIM), is a short linear
peptide motif found in autophagy receptors, which binds LC3-II and
thereby underlies selective autophagy. The LIR has a [W/Y/F]xx[L/I/
V] core motif, and receptor-ligand interaction occurs through
formation of an intermolecular b-sheet via hydrophobic interactions
between the LIR motif and the conserved W and L sites on Atg8
proteins. c Sequence alignment of reported mitophagy receptor core
LIR motifs and neighboring upstream and downstream regions.
Phosphorylation can positively or negatively regulate LIR activity.
d Two main groups of autophagy receptors target mitochondria. E3
ligase-mediated ubiquitylation of OMM proteins recruits ubiquitin-
binding, LIR motif-containing receptors, which leads to the binding
of receptors and engagement of sequestration by autophagosomes.
Alternatively, a group of autophagy receptors contain a transmem-
brane domain and are constitutively targeted to the OMM. LIR
activity of these mitophagy receptors is regulated by phosphorylation
events
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Mitophagy receptor systems
The PINK1/Parkin program targets mitophagy
receptors to depolarized mitochondria
via ubiquitylation of the OMM
To date, the best understood mitophagy system is con-
trolled by the serine/threonine kinase PINK1 (PTEN-
induced putative kinase 1) and the E3 ligase Parkin1 [71]
(Fig. 5a). Herein, PINK1 serves as the sensor for the
mitochondrial polarization state. In respiring, polarized
mitochondria, PINK1 is imported into the mitochondrial
intermembrane space and rapidly degraded through com-
bined activities of the protease PARL (presenilin-
associated rhomboid-like protein) and the proteasome [72,
73], thereby maintaining low basal PINK1 levels under
Fig. 5 Mitophagy program pathways: triggers and post-translational
regulation. a Upon mitochondrial depolarization PINK1 is stabilized
at the OMM, resulting in phosphorylation of ubiquitin and Mfn2 and
consequent recruitment of the E3 ligase Parkin. In the cytosol, Parkin
de-ubiquitylation by USP8 is required for mitochondrial transloca-
tion. At the mitochondria, Parkin ubiquitylates OMM proteins,
resulting in recruitment of ubiquitin-binding autophagy receptors
such as p62, OPTN, and NBR1 which then can attach to autophago-
somes via their LIR motifs. In addition, PINK1 directly recruits
autophagy receptors OPTN and NDP52 through generation of
phospho-ubiquitin. AMBRA1 can increase Parkin-mediated mito-
phagy by direct binding with LC3 and local autophagy stimulation.
Sequestration is coordinated by the Rab7 GTPase-activating protein
TBC1D15, which localizes to mitochondria by binding Fis1 and binds
forming autophagosomes via a LIR. b Bnip3 is induced by hypoxia,
and localizes to the OMM via one transmembrane domain. Bnip3 LIR
activity requires serine 17 phosphorylation, and is enhanced by serine
24 phosphorylation. Responsible kinase(s) and phosphatase(s) have
not yet been identified. Pro-survival Bcl-xL activity functions to
enhance Bnip3 binding to LC3. Nix contains an identical SWxxL LIR
motif and is expected to undergo similar regulation by phosphory-
lation. c FUNDC1 contains three transmembrane domains which
accomplish its OMM localization. Under normal conditions, Src
kinase phosphorylates tyrosine 18 and thereby inactivates the
FUNDC1 LIR. Hypoxia inactives Src kinase, permitting FUNDC1
LIR-mediated binding to autophagosomes. As a second negative
regulatory mechanism, CK2 phosphorylates FUNDC1 at serine 13,
inhibiting its LIR activity, and PGAM5 phosphatase antagonizes this
reaction. The pro-survival Bcl-xL can bind PGAM5, inhibiting its pro-
mitophagy activity. Under hypoxia and in response to depolarization
serine 17 phosphorylation by ULK1 enhances LIR activity.
d Bcl2L13 induces Drp1-independent mitochondrial fragmentation
and is a LIR-containing mitophagy receptor and mammalian homo-
logue of yeast Atg32 mitophagy protein. e, f Mitophagy receptor
systems undergo crosstalk with mitochondrial apoptosis. e Pro-
survival Bcl-2 signaling suppresses Parkin translocation to mitochon-
dria, and pro-apoptotic BH3-only proteins can activate Parkin-
mediated mitophagy. At longer timescales, Parkin ubiquitylates pro-
survival Mcl-1, resulting in its degradation and consequent activation
of mitochondrial apoptosis. f Bnip3 LIR and BH3 domains confer
dual functionality during apoptosis. Under conditions of LIR inacti-
vation, the BH3-only protein Bnip3 increases TNF-mediated caspase
activation. Under conditions of engaged LIR activity, the increased
degradation of mitochondria can suppress the mitochondrial partic-
ipation in apoptosis activation. Green arrows indicate positive
regulation; red arrows indicate negative regulation
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normal conditions. Mitochondrial depolarization inacti-
vates its import and proteasomal degradation, leading to
PINK1 accumulation on the OMM and resulting in
recruitment of Parkin from the cytosol. Parkin translocation
to mitochondria has been reported to involve two mecha-
nisms. PINK1 at the OMM phosphorylates Mfn2 at serine
442 and threonine 111, and phosphorylated Mfn2 can act as
a receptor to recruit Parkin [74]. In addition, PINK1
phosphorylates ubiquitin at serine 65 [75, 76], and the
ubiquitin-like domain of Parkin at serine 65 [77], which
drive Parkin recruitment to the OMM and activation of its
E3 ligase activity [78]. Once activated and recruited, Par-
kin E3 ligase activity results in the ubiquitylation of
numerous OMM proteins [57, 71], which leads to the
recruitment of different LIR-containing autophagy recep-
tors which bind ubiquitin-tagged OMM proteins, including
p62/SQSTM1 [79], optineurin [55] and NBR1 [56, 80]
(Fig. 4d). Mechanistically, p62 has a role in clustering
mitochondria during mitophagy [55, 81, 82], and has been
reported to be required [79], or dispensable in downstream
mitochondrial degradation [55, 81]. Recently, optineurin
was shown to act as the LIR-dependent autophagy receptor
downstream of Parkin activation [55]. Furthermore, opti-
neurin can localize TBK1 to p62, and phosphorylate p62 at
serine 403 phosphorylation which positively regulates p62
ubiquitin binding [83], generating a feedforward mecha-
nism enhancing p62 targeting of mitochondria. Further,
mitochondrial Parkin binds the autophagy-promoting pro-
tein AMBRA1 [84]. In response to mitochondrial
depolarization, AMBRA1 interacts with Parkin at the
OMM and contributes to Parkin-mediated mitophagy via
local stimulation of autophagosome formation [58, 59].
Moreover, AMBRA1 was recently shown to bind LC3
through a LIR motif during Parkin-mediated mitophagy,
and forced targeting of AMBRA1 to the OMM resulted in
efficient depletion of mitochondria, independent of Parkin
[85], identifying AMBRA1 as a mitophagy receptor. In
addition, in the absence of Parkin, mitochondrial-targeted
AMBRA1 was reported to activate mitochondrial ubiqui-
tylation, without recruiting p62. However, the E3 ligase
identity, and whether ubiquitylation recruits other ubiqui-
tin-binding autophagy receptors, remains to be determined.
A recent study using TALEN and CRISPR/Cas9 gen-
ome editing for combinatorial knockout of five autophagy
receptors further consolidates our understanding of the
relative contributions of specific autophagy receptors to
PINK1/Parkin-mediated mitophagy [86]. Here, p62 and
NBR1 were found to be dispensable, and primary but
redundant autophagy receptor functions were defined for
OPTN and NDP52. Furthermore, PINK1-mediated gener-
ation of Ser65 phospho-ubiquitin [75, 76] was revealed as a
primary mitophagy signal, autonomously capable of
recruiting OPTN and NDP52, thereby proposing a new
model within which Parkin functions to amplify PINK1-
initiated mitophagy signaling.
Deubiquitylation and modulation of Parkin-mediated
mitophagy
Ubiquitylation is a reversible process, and recent work has
evidenced a central role for deubiquitylating (DUB)
enzymes in the regulation of mitophagy (Fig. 5a). Parkin
can ubiquitylate itself, resulting in its reduced recruitment
to depolarized mitochondria. USP8 deubiquitylation of
auto-ubiquitylated Parkin is required for its localization to
depolarized mitochondria, and thereby for efficient acti-
vation of mitophagy [87]. In addition, acting as negative
regulators, the ubiquitin-specific proteases USP30, which
localizes at the OMM via a transmembrane domain [88],
and USP15, which can fractionally localize to mitochon-
dria, remove Parkin-ligated ubiquitin from OMM proteins
[88, 89]. Importantly, both USP30 and USP15 knockdown
increased the cellular capacity for mitophagy, suggesting
the potential for pharmacological enhancement of
mitophagy.
Constitutively OMM-localized mitophagy receptors
are phospho-regulated
In contrast to the PINK1/Parkin mitophagy system, which
involves Parkin translocation to mitochondria and subse-
quent ubiquitin-dependent recruitment of mitophagy
receptors, a group of LIR-containing mitophagy receptors,
upon expression, constitutively localize at the OMM via
transmembrane domains (Fig. 4d). This group of mito-
phagy receptors is transcriptionally regulated, and
engagement of mitophagy receptor activity is controlled
through the phosphorylation status of their LIR.
Bnip3 and Bnip3L/Nix: OMM-localized mediators
of mitophagy and apoptosis signaling
Bnip3 (BCL2/adenovirus E1B 19 kDa interacting protein 3)
and its homologue Bnip3L/Nix are atypical members of the
pro-apoptotic Bcl-2 subfamily of BH3-only proteins [90],
sharing 56 % of the amino acids sequence identity [91].
Both, upon expression, are inserted into the OMM via their
C-terminal transmembrane domains, with the N-terminus
oriented toward the cytoplasm [66, 92]. At the mitochondria,
the BH3 domains of Bnip3 [92] and Nix [93] suppress the
function of anti-apoptotic Bcl-2 proteins. In addition to its
apoptotic functions, Bnip3 was reported to trigger autophagy
[94] and mitophagy [60], and Nix was found to mediate
mitochondrial clearance during blood cell development [62,
63]. It was later discovered that both Bnip3 and Nix contain
identical N-terminal LIRs (WxxL) [52, 61, 64] (Fig. 4c),
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thereby providing mechanistic explanation for their mito-
phagy-inducing function (Fig. 5b).
In addition to this function in coupling OMMs with
autophagosomal membranes via their LIR, Bnip3 and Nix
undergo crosstalk with the autophagy regulation machin-
ery. Hypoxia-induced autophagy was shown to be
supported by Bnip3 and Nix binding to Bcl-2 and conse-
quent disruption of Bcl-2 binding to Beclin 1 [95].
Furthermore, Bnip3 and Nix can bind to the mTOR-acti-
vating protein Rheb via their N-terminus, which was
associated with reduced activation of mTOR and enhanced
autophagy [96]. Under glutamine-mediated enhancement
of mitochondrial respiratory activity, Rheb interacted with
Nix to induce mitophagy, presumably to meet an increased
mitochondrial quality control demand [97]. In this study,
Rheb localization to mitochondria did not alter mTOR
activity, and it remains to be determined whether Rheb
further functions to regulate Nix interaction with LC3.
We have recently shown that the mitophagic activity of
Bnip3 is controlled through the phosphorylation state of
serine residues adjacent to the LIR [52]. Phosphorylation of
serine residues 17 and 24 flanking the Bnip3 LIR specifi-
cally promotes binding to LC3B and GATE-16 (Fig. 4c).
Interestingly, phosphorylation of Bnip3 at serine 17 is a
prerequisite for LC3B and GATE-16 binding, whereas
phosphorylation at serine 24 further increased the affinity
for both LC3B and GATE-16. Similar to Bnip3, Nix con-
tains a SWxxL LIR motif and activity of its LIR is serine
phosphorylation regulated (own unpublished results). To
date it remains undetermined which kinases and phos-
phatases are responsible for controlling the
phosphorylation state of the Bnip3 and Nix LIRs.
FUNDC1
The OMM-localized protein FUNDC1 contains three
transmembrane domains and an N-terminal cytosolic LIR
motif (YxxL) for binding to LC3 and GABARAP proteins
[53] (Fig. 4c). Also FUNDC1 undergoes positive and
negative regulation by phosphorylation, at residues within
and preceding the LIR. Under normal conditions, FUNDC1
mitophagy receptor activity is kept in check through inhi-
bitory phosphorylation by Src kinase at tyrosine 18 [53]
and by casein kinase 2 (CK2) at serine 13 [98] (Fig. 5c). In
response to hypoxia or mitochondrial uncoupling, PGAM5
dephosphorylates CK2-phosphorylated serine 13 of
FUNDC1 to activate LC3 binding [98]. In addition, ULK1
phosphorylates serine 17 of the FUNDC1 LIR motif,
resulting in increased LC3 binding [99]. Interestingly, Bcl-
xL antagonizes PGAM5-mediated dephosphorylation of
FUNDC1 and thereby prevents LC3 binding [100], sug-
gesting that in the FUNDC1 system, anti-apoptotic
signaling antagonizes the mitophagy response.
Bcl2L13/Bcl-Rambo
Bcl2L13 (Bcl2-like 13 or Bcl-Rambo) is an atypical Bcl-2
family member, which contains four BH motifs, but does
not bind pro-death or pro-survival Bcl-2 members, and
signals apoptosis via its C-terminal transmembrane
domain, which targets the OMM [68]. Recently, Bcl2L13
was identified as a mitophagy receptor based on similarity
to the yeast mitophagy receptor Atg32, with a WxxL LIR
motif [65] (Fig. 4c). Bcl2L13 expression is sufficient to
induce mitochondrial fragmentation and target fragmented
mitochondria to autophagosomes and endolysosomes
(Fig. 5d). All BH domains are required for fragmentation,
but in contrast to other modes of mitophagy, fragmentation
occurred independent of Drp1. Further, the authors report
that CCCP-induced mitochondrial clearance by Bcl2L13
was independent of Parkin, and Bcl2L13 does not induce
mitochondrial ubiquitylation in response to CCCP. It is
suggested that increased Bcl2L13 levels activate its LIR
via phosphorylation: CCCP rapidly increased Bcl2L13
levels, and the mutation of phosphorylation target S272
[101] to alanine reduced total serine phosphorylation of
Bcl2L13. Further, while the Bcl2L13 S272A mutant frag-
mented mitochondria, mitochondria did not co-localize
with autophagosomes. Mutating S272 to phospho-mim-
icking glutamic or aspartic acid residues, and identifying
the kinase and phosphatase responsible, will be instru-
mental for further elucidating the role of Bcl2L13 LIR
phospho-regulation.
It is remarkable that all known transmembrane-domain
OMM-localized mitophagy receptors contain conserved
serine/threonines preceding the LIR (Fig. 4c), indicating
that LIR phospho-regulation mechanisms represent a cru-
cial target for altering mitophagy receptor function. Also
optineurin contains a serine preceding the LIR, which is
required for LC3 binding and its participation in xeno-
phagy [46], rendering it likely that its role in mitophagy is
also positively regulated by phosphorylation. Likewise,
AMBRA1 contains two tyrosine residues preceding the
LIR, which would also be expected to be phospho-regu-
lated (Fig. 4c). Of note, opposed to FUNDC1, we observed
that the phosphorylated state of serine 13 of Bnip3 had no
impact on LIR activity [52], suggesting that the specific
residues preceding the core LIR motif contribute to its
regulation.
Lipid-mediated mitophagy
In addition to protein mitophagy receptors, the lipids cer-
amide and cardiolipin, when localized to the OMM can
directly bind LC3 and engage mitophagy [69, 70].
Increased levels of C18-ceramide at the OMM, either
through exogenous addition, or endogenously-generated by
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ceramide synthase 1 (CerS1), specifically bind to LC3, to
induce Drp1-dependent mitophagy [69]. Intriguingly,
knockdown of LC3B permitted tumor growth under con-
ditions of increased ceramide production, indicating
ceramide-mediated mitophagy promotes cell death. Fur-
thermore, the anti-cancer agent sodium selenite was shown
to activate this program via upregulation of CerS1. This
intriguing example for a pro-death mode of mitophagy is
independent of mitochondrial apoptotic signaling and cas-
pase signaling, and presents a model to elucidate the
molecular basis of mitophagic cell death.
Alternatively, cardiolipin, a negatively charged phos-
pholipid, can bind LC3B in response to sub-apoptotic
mitochondrial dysfunction. Under normal conditions, most
cardiolipin is localized to the IMM, and in response to
mitochondrial stress phospholipid scramblase-3 (PLS3)
redistributes cardiolipin to the OMM, where it then can
bind to LC3B [70]. Interestingly, mutational analysis of
LC3B indicates that ceramide interacts with I35 and F52 of
LC3B, while cardiolipin undergoes electrostatic interac-
tions with positively charged R11 and R10, which are
found in LC3A and LC3B and conserved in the homolo-
gous region of LC3C (R16 and K17), but not in members
of the GABARAP subfamily (Fig. 4a). Notably, I35 and
F52 bind to the LIR of p62, and R10 and R11 bind aspartic
acid residues preceding the p62 LIR [51]. However, it
remains to be determined whether either of these lipids
functionally impact protein autophagy receptor interactions
with LC3B.
Crosstalk between mitophagy receptor systems:
a lack of information concerning the level
of complexity
It is notable that among the different mitophagy receptor
systems, our understanding of crosstalk between mito-
phagy modes is, so far, restricted to Nix and Parkin
pathways. In cell lines, Nix has been shown to promote
Parkin translocation to mitochondria, and Parkin-mediated
mitophagy [102, 103], and Parkin ubiquitylation of Nix
recruits the mitophagy receptor NBR1 [103]. In future
work, we propose that mutationally inactivating and acti-
vating the LIR using non-phosphorylatable and phospho-
mimicking mutations, in combination with genome editing
approaches, will serve as fundamental approaches for
elucidating whether/which mitophagy receptors form
competitive, additive or exclusive programs. Moreover,
similar to Parkin, cardiolipin-mediated mitophagy is acti-
vated in response to mitochondrial poisons in neuronal
cells [70]. Thus, it will be interesting to determine the
contributions of lipids to receptor-mediated mitophagy.
Autophagosomal sequestration of mitochondria
While autophagy receptors capture autophagosomes at
mitochondria via their LIR, an outstanding fundamental
question for all mitophagy programs is how autophago-
somes are localized to dysfunctional mitochondria, and
how the sequestration process is coordinated. Upon depo-
larization, in Parkin-overexpressing cells, autophagy
initiating factors, including ULK1, DFCP1 and WIPI-1,
localize to mitochondria independently of LC3 [104],
mediated by PINK1-recruited autophagy receptors NDP52
and OPTN [86]. Together, these data suggest that
autophagosomes are produced at damaged mitochondria
and LC3 processing can be localized for the downstream
engulfment of mitochondria into autophagosomes. One
candidate for such local regulation is AMBRA1 which was
shown to exert pro-autophagic activity at mitochondria [58,
59] and additionally contains a LIR [85] which may locally
activate and direct autophagosome capture at depolarized
mitochondria. In addition, the cellular energy sensor
AMPK (50 AMP-activated protein kinase), which activates
autophagy [105] and mitophagy [20], is spatially localized
at mitochondria [106], providing a possible sensing
mechanism to signal local production of autophagosomes.
We observed that expression of a Bnip3 LIR mutant
resulted in increased autophagosome content in regions
localized next to mitochondria, albeit without mediating
sequestration [52], which is consistent with a mechanism of
localized autophagosome generation. Recent work has
yielded insight into the sequestration process. Rab7 and the
Rab GTPase-activating proteins (Rab-GAPs) TBC1D15
and TBC1D17 coordinate autophagosome sequestration of
Parkin-targeted mitochondria [107]. TBC1D15 and
TBC1D17 bind the OMM-localized, Drp1-binding protein
Fis1 and contain LIRs which coordinate autophagosome
binding to mitochondria. It remains to be determined if
Fis1-TBC1D15 interaction coordinates OMM-localized
FUNDC1/Bnip3/Nix-mediated mitophagic sequestration.
Of note, sequestration and degradation of mitochondria
requires increased autophagic activity. Thus, the cellular
autophagic capacity may be an important limiting factor.
Autophagic capacity is under the control of the transcrip-
tion factor EB (TFEB), which promotes expression of
autophagosomal and lysosomal genes [108]. mTOR inhi-
bits TFEB by phosphorylation, thereby coupling autophagy
induction and lysosomal activity [109]. Indeed, increased
TFEB signaling was shown to enhance Bnip3-induced
mitophagy [110] and TFEB together with additional MiT/
TFE family members contributes to Parkin-mediated
mitophagy [111], supporting that the cellular autophagic
capacity is linked to mitophagic efficiency.
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Transcriptional level regulation of mitophagy
receptors
Mitophagy programs are modulated by different tran-
scriptional responses (Fig. 6). Parkin expression is induced
by mitochondrial and endoplasmic reticulum stress via the
PERK-ATF4 signaling pathway, and dominantly repressed
by c-Jun [112]. In addition, nuclear p53 upregulates Parkin
expression [113], while cytosolic p53 suppresses Parkin
targeting of mitochondria [114], and Parkin suppresses p53
expression [115], suggesting a multi-tiered homeostatic
feedback. The mitophagy receptor Bnip3 is prominently
regulated at the transcriptional level. Bnip3 expression is
driven by hypoxia-inducible factor HIF1 [116–118], which
is enhanced by Ras [119] as well as E2F-1 [120], and
antagonized by NFjB [121]. Similar to Bnip3, in human
tumor cells also Nix is upregulated during hypoxia, via
HIF1 [118] and p53 [122]. In cardiac cells on the other
hand, Nix is constitutively expressed, and enhanced
expression is driven by Gq-signaling via the transcription
factor SP1 [123]. In addition, activated FOXO3 induces
Bnip3 and Nix expression in fasting skeletal muscle [124].
However, under hypoxia FOXO3a suppresses HIF1-medi-
ated Nix expression via the transcriptional cofactor
CITED2 [125], suggesting negative feedback regulation
under hypoxic conditions.
Recently, microRNAs have emerged as negative regu-
lators of the cellular mitophagy capacity. During
erythrocyte maturation, the transcriptional repressor KAP1
(Kru¨ppel-associated box (KRAB)-associated protein 1)
[125] inhibits expression of miR-351 and hsa-miR-125a-
5p, which normally function to suppress Nix and mito-
phagy [126]. In addition, miR-137 negatively controls
expression of Nix and FUNDC1 [127]. Hypoxia-associated
down-regulation of miR-137 thereby permits mitophagy
receptor expression. In prostate cancer, the p53 inducible
miR-145 can suppress Bnip3 expression, thereby counter-
ing HIF1 upregulation [128].
Physiological and pathophysiological implications
of mitophagy
As the mechanisms of mitophagy unravel, so do the
physiological roles for mitophagy. Several lines of evi-
dence link familiar Parkinson’s disease to impaired
mitophagy. Mitochondria are defective in Parkinson’s
disease [129, 130]. Deletions and point mutations of Parkin
and PINK1 genes (PARK2 and PARK6, respectively) were
identified in early-onset Parkinson’s disease patients [71]
and these disease-associated mutations were shown to
mechanistically result in defective mitophagy [54, 73, 81,
131]. However, extrapolating findings from mechanistic
PINK1/Parkin studies to in vivo relevance has been a
subject of much debate: Most studies that have elucidated
the molecular events of Parkin-mediated mitophagy utilize
Fig. 6 Transcriptional regulation of mitophagy. a Under conditions
of mitochondrial and endoplasmic reticulum (ER) stress, Parkin
expression can be induced by the PERK/ATF4 pathway, and
suppressed by the JNK/c-Jun pathway. Further, p53 and Parkin
interactions form complex crosstalk. p53 can induce Parkin expres-
sion, and Parkin can inhibit p53 expression, forming a negative
feedback circuit. In addition, cytosolic p53 can inhibit Parkin
translocation to mitochondria. b Nix expression is induced by
G(q) signaling via SP1, by hypoxia via HIF1 and p53, and FOXO3.
Nix expression can be suppressed via FOXO3 activation of CITED2.
Both Nix and FUNDC1 are negatively co-regulated by microRNAs.
miR-351 and hsa-miR-125a-5p target Nix, and miR-137 co-targets
Nix and FUNDC1. c Bnip3 expression is increased by Ras activity
and induced during hypoxia by HIF1. E2F and FOXO3 activate, and
NFkB suppresses Bnip3 expression. Black arrows indicate post-
translational regulation; green arrows indicate transcriptional activa-
tion; red arrows indicate transcriptional repression
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a combination of artificial Parkin overexpression and
chemically-induced mitochondrial depolarization in cancer
cell lines. Notably, it was reported that, opposed to in
cancer cell lines, mitochondrial depolarization does not
lead to robust mitochondrial Parkin translocation in neu-
rons and this was linked to bioenergetics differences
between oxidative phosphorylation-dependent neurons and
glycolytic cancer cell lines [132]. Moreover, mitochondrial
Parkin translocation was shown to occur as a slow and
subcellularly restricted process in mature cortical neurons
[133], and Parkin accumulation was observed on only a
fraction of depolarized mitochondria in neuronal axons
[134]. Importantly, it was recently shown that Parkin-me-
diated mitophagy is constitutively engaged in primary
neurons, with PINK1 functioning as the limiting factor for
basal mitophagy [89]. In this study, inhibition of USP30,
which antagonizes Parkin-mediated mitophagy, increased
basal mitophagy by up to fourfold, and in vivo knockdown
of USP30 in drosophila was associated with survival.
Interestingly, a dominant negative USP30 mutant restored
mitophagy in response to PINK1 knockdown, suggesting a
fundamental suppressive action. However, it is important
to consider that these findings reflect basal neuronal
mitophagy activities, and further bioenergetic and oxida-
tive stress-activated studies will be required to determine
the extent to which USP30 regulates neuronal mitophagy
of dysfunctional mitochondria, and/or autophagy-indepen-
dent modes of selective mitochondrial degradation [135,
136]. Of note, Parkin knockout mice do not readily exert
neurodegeneration or associated motor phenotypes [71],
and Parkin knockout in mice with respiratory chain defi-
ciency caused by neuron-specific mitochondrial
transcription factor (Tfam) knockout did not impact
clearance of mitochondrial aggregates or progression of
neurodegeneration [137]. A recent study reports a neuro-
protective role for endogenous Parkin, in a model of Parkin
knockout mice with a mitochondrial dysfunction back-
ground caused by accumulation of mtDNA mutations due
to deficiency in DNA polymerase c [138]. However, while
Parkin knockout affected mitochondrial function, no effect
on mtDNA mutation burden was detected. Thus, it remains
to be determined whether Parkin-mediated mitophagy or
alternative functions of Parkin are key to its neuroprotec-
tive role in this context.
As mitophagy receptors also Bnip3 and Nix fulfill
physiological functions, in addition to their pro-apoptotic
function as atypical BH3-only proteins. Bnip3-mediated
mitophagy participates in mitochondrial homeostasis in
liver of adult mice to avoid metabolic defects [139] and is
engaged as a cytoprotective program during ischemia/
reperfusion injury in cardiac myocytes [52, 60, 140]. The
Bnip3 homologue Nix is transcriptionally upregulated
together with Bcl-xL during erythrocyte maturation [141],
to drive the removal of mitochondria [62, 63] via its
mitophagy receptor function [64]. Furthermore, mouse
cytomegalovirus-induced proliferation of antigen-specific
natural killer cells is associated with mitochondrial dys-
function, and Bnip3- and Nix-mediated mitophagy were
recently shown to be essential in the survival of memory
natural killer cells [142]. In heart cells, both PINK1/Parkin-
and Bnip3-/Nix-mediated mitophagy were connected to
maintaining homeostasis. Parkin-deficiency resulted in
enlarged cardiomyocyte mitochondria and respiration
defects in Drosophila heart tubes [74]. Similar cardiac
defects were observed in Mfn2 knockout mice, with a
proposed connection to impaired Mfn2-mediated recruit-
ment of Parkin [74]. However, as Mfn2 is a crucial
regulator of mitochondrial morphology as well as of
mitochondrial-ER junctions, a causative role for altered
Mfn2-mediated mitophagy in cardiomyopathy remains to
be established. Nix knockout mice developed cardiomy-
opathy, which developed faster in Bnip3 and Nix double
knockout mice [143]. These in vivo findings demonstrate
cardioprotective roles for Parkin, Bnip3 and Nix mitophagy
programs in the regulation of mitochondrial homeostasis,
and further suggest limits to compensating roles. Of note,
an important mechanistic distinction from depolarization-
driven mitophagy is that Bnip3 can induce mitophagy of
polarized mitochondria [52], supporting divergent func-
tional roles between mitophagy programs: In addition to
being engaged in order to respond to dysfunctional mito-
chondria, Bnip3 and Nix appear to be responsible for basal
turnover [143], or engaged for developmental [62–64] and
immune response programs [142].
Mitophagy and cancer
Conceptually, a role of mitophagy in cancer is an intriguing
hypothesis: Subpopulations of dysfunctional mitochondria
can transform cells and promote tumorigenesis [144],
suggesting mitophagy could function as a tumor suppressor
mechanism. Alternatively, in cancer cells, mitophagy
scavenging of pro-apoptotic mitochondria could be cyto-
protective. However, to date the roles for mitophagy
programs in cancer remain unclear. For example, Parkin
may function as a tumor suppressor, as Parkin mutations
are common and result in cell cycle deregulation [145,
146]. Furthermore, the expression of Bnip3 and Nix is
commonly deregulated in cancer. Both Bnip3 and Nix
translation is increased in hypoxic and peri-necrotic tumor
regions [118, 147]. High Bnip3 is reported to correlate with
invasive tumor behavior in breast [147] and colorectal
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[148] cancers, and poor prognosis in non-small cell lung
[149], prostate [128] and endometrial [150] cancers. In
addition, low Bcl2L13 expression correlates with good
outcome in childhood acute lymphoblastic leukemia [151].
On the other hand, Bnip3 expression can be silenced in
leukaemias [152] and pancreatic [153], colorectal and
gastric [154] cancers, and lost Bnip3 [153] or high
AMBRA1 [155] expression in pancreatic cancer correlate
with worsened prognosis. Thus, these in vivo cancer
studies suggest contradicting roles for mitophagy receptors
and signaling regulators in cancer, likely due to their
simultaneous participation in mitophagy-independent sig-
naling. Therefore, the targeting of specific autophagy
receptors in in vivo experiments, for various cancer types
and treatment conditions, are required for translational
understanding.
Such an approach was recently performed in a mouse
model study of metastatic breast cancer [156]. The authors
report that deleting Bnip3 promoted tumor growth and
malignancy, and resulted in the accumulation of dysfunc-
tional, ROS-producing mitochondria. The resulting
increased oxidative stress was shown to activate HIF1a-
mediated glycolysis and angiogenesis. Consistently, in
human breast cancer low Bnip3 correlated with high HIF1a
and poor patient prognosis.
Role of mitophagy in apoptosis signaling
While it is well established that autophagy and apoptosis
signaling undergo pronounced regulatory crosstalk [157],
our understanding of the relationship between mitophagy
and apoptosis is limited. Recent findings indicate that
Parkin undergoes extensive crosstalk with apoptosis path-
ways (Fig. 5e). Mitochondrial translocation of Parkin was
shown to be blocked by pro-survival Bcl-2 proteins, and
activated by BH3-only proteins under conditions of
inhibited caspase activity [80]. At longer time scales,
Parkin can enhance mitochondrial uncoupling-induced
apoptosis through degradation of anti-apoptotic Mcl-1
[158]. Consistent with this action, knockdown of USP30,
which antagonizes Parkin-mediated mitophagy by deubiq-
uitylating OMM proteins [89], sensitizes cells to activation
of the mitochondrial apoptosis pathway [159]. This finding
suggests that USP30 would drive mitochondria toward a
mitophagy versus apoptosis decision event, and highlights
the requirement for further mechanistic understanding.
We further reported that pro-survival Bcl-xL positively
regulated the binding of Bnip3 to LC3B, and enhanced
mitochondrial sequestration [52] (Fig. 5f). Notably, this
regulation differs from FUNDC1, which is negatively
regulated by Bcl-xL [100], suggesting separate and mutu-
ally exclusive mitophagy pathways.
Functionally, ectopic expression of wild type or LIR-
mutated Bnip3 [61], or knockdown of FUNDC1 during
hypoxia [53] have no measured impact on apoptosis
induction. However, pre-activation of Bnip3-mediated
mitophagy through expression of constitutively active
Bnip3 receptor prior to TNF (tumor necrosis factor) treat-
ment, significantly reduced effector caspase activation
[52]. These findings suggest that enhanced mitophagy
activity, and/or delayed activation of mitochondrial outer
membrane permeabilization, can reduce the mitochondrial
capacity to amplify apoptosis. However, different positive
and negative feedbacks between individual mitophagy
programs and both pro-survival and pro-death apoptosis
signaling, operate at different time scales, and undergo
crosstalk [102]. Therefore, it remains to be systematically
determined to what extent, in which tissues, and under
which (patho)physiological conditions, mitophagy recep-
tors are expressed and regulated. Importantly, the
characterized phospho-mimicking mutations [52, 99] will
be instrumental in the elucidation of mitophagy receptor
function in cell culture and in in vivo models.
Non-canonical modes of mitochondrial processing
by endolysosomes
In addition to the above described canonical macroau-
tophagy-mediated modes of mitophagy, mitochondrial
stress can engage autophagy-independent endolysosomal
interactions with mitochondria (Fig. 7). While chemical-
induced mitochondrial depolarization activates PINK1-
mediated mitophagy, under conditions of low mitochon-
drial bioenergetic stress and enhanced oxidative stress, and
prior to depolarization, PINK1 and Parkin induce mito-
chondria-derived vesicles (MDVs) which target oxidized
mitochondrial proteins to lysosomes, independently of
autophagy [135, 160]. The MDV pathway is proposed to
function as a homeostatic quality control mechanism for
damage levels which do not require the sacrifice of the
entire mitochondrion. In addition, in response to oxidative
stress the p53-induced Mieap (Mitochondria-eating pro-
tein) induces the autophagy- and Parkin-independent
interaction of large endolysosome-like organelles with
mitochondria [161, 162]. Mieap activity requires the
interaction with Bnip3 and Nix [163], and is proposed to
operate in mitochondrial quality control.
We recently reported that expression of the canonical
BH3-only proteins tBid, BimEL, Bik and Bad, or treat-
ment with apoptosis inducers TNF or staurosporine,
triggers E3 ligase XIAP (X-linked inhibitor of apoptosis
protein)-mediated mitochondrial outer membrane perme-
abilization and XIAP entry into mitochondria [164, 165].
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XIAP action at mitochondria results in prominent ubiq-
uitylation at the OMM and IMM, and, intriguingly,
autophagy-independent movement of endolysosomal
machinery into mitochondria [164]. Inside mitochondria,
XIAP catalyzes the proteasome- and lysosome-mediated
degradation of its endogenous inhibitor Smac [164], and
consequently reduced effector caspase activation during
intrinsic apoptosis [165]. Intramitochondrial recruitment
of endolysosomes is activated independently of Parkin,
Bnip3 or Nix LIR receptor activity. Interestingly,
expression of Bnip3 or Nix LIR mutants, with lost
mitophagy receptor function, likewise results in activa-
tion of this novel pathway [164].
Notably, these three non-canonical modes of mito-
chondrial processing do not require LC3-decorated
autophagosomes, and instead appear to result from direct
interorganellar interactions between mitochondria and
endolysosomes [135, 161, 164]. One possible advantage
over canonical mitophagy, is that direct interactions
between endolysosomes and mitochondria can be
engaged at faster time scales, as they engage pre-existing
organelles.
Experimental approaches to detecting mitophagy
In this section, we highlight assays to detect mitophagy
induction and capacity (Fig. 8). Overall, when assessing
mitophagy it is important to apply a variety of techniques
and to monitor both mitophagy induction and efficiency of
degradation.
High-resolution imaging and biochemical detection
and quantification of mitophagy
Mitophagy was first detected using electron microscopy
[21], and remains a standard for nanometer analysis of
organelle ultrastructure and mitochondrial sequestration.
More recently, mitophagy can be directly observed by
confocal or widefield fluorescence microscopy, based on
sequestration of mitochondria by GFP-LC3-labeled
autophagosomes [60] (Fig. 8a). Of note, mitophagy pro-
grams vary in the composition of the autophagy
machineries. For instance, Nix poorly binds LC3B [64],
while Bnip3 preferentially binds LC3B and poorly binds
GATE16 [52]. Thus, when assessing novel mitophagy
settings, responses of both LC3 and GABARAP subfami-
lies should be determined. Alternatively, GFP-Rab7 is a
suitable tool to detect downstream mitochondrial entry into
endolysosomes, independent of LC3 homologue specificity
[52] and to capture non-canonical modes of endolysosomal
processing of mitochondria [161, 164, 166]. Furthermore,
Fig. 7 Alternative, autophagy-independent modes of mitochondrial
processing by endolysosomes. a Under sub-threshold conditions of
mitochondrial stress, and prior to depolarization, PINK1 and Parkin
mediate a pathway delivering mitochondria-derived vesicles (MDVs),
carrying damaged mitochondrial components, directly to endolyso-
somes. b Under conditions of oxidative stress, Nix and Bnip3 can
bind with MIEAP (mitochondrial-eating protein), to induce autop-
hagy-independent interactions of mitochondria with lysosome-like
organelles. c Activity of canonical BH3-only proteins, or mitochon-
drial depolarization, triggers mitochondrial ubiquitylation by the
endogenous caspase inhibitor and E3 ligase XIAP and Bax/Bak-
mediated entering of XIAP into mitochondria. Mitochondrial activity
of XIAP recruits endolysosomal trafficking machinery into mito-
chondria, leading to the degradation of its inhibitor Smac, thereby
reducing the apoptotic potential of mitochondria
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the GFP-LC3-G120A mutant which cannot be conjugated
to PE and insert into autophagosomal membranes [39] is
applicable to ensure that mitochondrial localization of
GFP-LC3 corresponds to autophagosome sequestration
[52].
Importantly, when detecting mitochondria using fluores-
cent dyes, caution and proper controls are paramount.
MitoTracker dyes accumulate inside mitochondria based on
their membrane potential, and therefore will not efficiently
label dysfunctional mitochondria. Moreover, different
mitochondrial dyes may be retained differently within
mitochondria, dependent on, or independent of, the mito-
chondrial polarization state [167]. Therefore, strict controls
need to be employed to distinguish between changes in
mitochondrial mass and the fraction of polarized mito-
chondria. Alternatively, mitochondria-targeted fluorescent
proteins can be used to detect mitochondria [168]. However,
also here it needs to be considered that protein import into
mitochondria is lost following depolarization [169], possibly
resulting in mislocalization of reporter proteins to the
Fig. 8 Methodologies to measure mitophagy. Biochemical and
imaging-based assays can measure different aspects of mitophagy
program activities. a Mitochondria-containing autophagosomes can
be detected via imaging of fluorescent protein (FP)-LC3-labeled
autophagosome colocalization with immunofluorescence or FP-
labeled mitochondria. Western blot and immunofluorescence detec-
tion of IMM and matrix proteins is most specific for detecting
mitophagic degradation events. Mito-autolysosomes can be detected
using FP-Rab7. b MitoTimer is a tetramer which matures as a green-
to-red fluorescent protein. MitoTimer can be used under inducible-
and constitutive-expression to analyze mitochondrial quality control
dynamics. c Mitochondrial entry into the autolysosome and subse-
quent degradation can be measured using FP sensors targeted to
mitochondria, that are sensitive to low pH and resistant to degradation
by lysosomal hydrolases. Mito-Keima fluoresces green at neutral pH
in the cytosol, and red upon entry into acidic autolysosomes. Mito-
Tandem is a mitochondria-targeted RFP–GFP fusion. GFP fluores-
cence is acid-quenched while RFP fluorescence remains stable also at
low pH, permitting live cell analysis of mitochondrial presence in
autolysosomes. Note, lysosomal hydrolases degrade GFP more
efficiently than RFP, permitting detection of mitophagy in fixed
cells. d Example co-immunoprecipitation demonstrating phospho-
regulated Bnip3 mitophagy receptor engagement, i.e., Bnip3 LIR
binding with LC3B. MCF7 cells stably expressing GFP-LC3B were
transfected with RFP-Bnip3 WT, or LIR-inactive 2SA or LIR-
activated 2SE mutants. At 48 h of expression, co-immunoprecipita-
tions (IP) were performed with anti-GFP antibody-coupled magnetic
beads. Whole cell lysates (input) and IP samples were analyzed by
western blotting (WB). This research was originally published in Zhu
et al. [52].  The American Society for Biochemistry and Molecular
Biology
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cytosol, depending on the experimental time scales. Thus,
mitochondria-targeted fluorescent protein sensors may not
be suitable for all applications. The use of antibodies tar-
geting endogenous mitochondrial proteins, for mitophagy
detection by either immunofluorescence or Western blotting,
can circumvent this obstacle. When choosing mitochondrial
protein readouts, it is of note that Parkin can activate the
proteasomal degradation of OMM proteins in response to
CCCP in the absence of mitophagy [170]. Assessing degra-
dation of multiple mitochondrial proteins revealed that
cytochrome c and VDAC1 are more rapidly degraded, than
Complex Va, Complex III Core 1 and cyclophilin D [171],
suggesting the latter proteins as more suitable readouts when




As a complementary approach, the use of high-content
sensors can provide spatio-temporal information concern-
ing mitochondrial biogenesis and lysosomal processing.
The MitoTimer sensor (Fig. 8b) was developed based on
the tetrameric fluorescent protein drFP583, a derivative of
DsRed2, which emits green fluorescence when synthesized,
and then progressively shifts to red fluorescence upon
oxidation [172]. Two approaches have been developed to
extrapolate mitophagy dynamics from MitoTimer fluores-
cence maturation kinetics. First, using pulsed biosensor
expression via a doxycycline-inducible vector, the tempo-
ral evolution of red-to-green fluorescence ratio can be used
to evidence both mitochondrial turnover and biogenesis
[173]. Alternatively, using a constitutive promoter, changes
in MitoTimer red-to-green ratio were used to detect chan-
ges to mitophagy dynamics in vivo [174]. Of note, while
oxidation underlies the green-to-red conversion, it is not
fully understood to what extent mitochondrial dysfunction,
i.e., ROS production, would influence maturation [172]. A
similar tool is mt-Keima (Fig. 8c), which is a mitochon-
drial matrix-targeted ratiometric pH-sensitive fluorescent
protein that fluoresces red at low pH and green at higher pH
[175]. Mt-Keima directly reports entry of mitochondria
into lysosomes [89], and was used to evidence endogenous
activity of Parkin-mediated mitophagy [89].
RFP–GFP tandem-based mitophagy sensors
An alternative biosensor approach targets a tandem RFP–
GFP fusion protein to mitochondria (Fig. 8c), where under
live cell conditions GFP fluorescence is quenched under
acidic conditions of the late endosome/lysosome, while
RFP fluorescence remains stable [176]. RFP–GFP targeted
to the OMM has been applied to report Parkin-induced
mitophagy, and was used for a drug screen, identifying iron
chelators as Parkin-independent activators of mitophagy
[177]. Similarly, an IMM-targeted RFP–GFP tandem sen-
sor was used to evidence hepatitis B virus-induced
activation of mitophagy [178].
For all above fluorescence-based mitophagy assays, an
important consideration is that each cell has 100s–1000s of
mitochondria, making manual scoring of high-resolution
imaging difficult and subjective. Thus, rigorous quantifi-
cation of single cells and cell populations is required.
Moreover, it is necessary to analyze total cellular fluores-
cence through the Z-axis, as the mitophagic response is not
uniform throughout all optical slices of a cell. For imaging,
the use of high-resolution objectives (609–1009) and
optical sectioning with 300 nm step sizes is advisable.
Subsequently, using image analysis software, e.g., Fiji/
ImageJ (http://fiji.sc/Fiji), plane-by-plane co-localization
can be applied to quantify the extent of mitophagy.
Alternatively, images can be manually segmented, and the
fraction of mitochondria that is co-localized with
autophagosomes can be extrapolated as a fractional cell
response. Importantly, a large sample of images must be
analyzed to provide meaningful statistics. In addition, high
sampling of cells (100s–1000s), as can be achieved using
image cytometry [52], or flow cytometry [173], provides a
quantitative measure of the number of cells in a population
exhibiting a mitophagy response, as well as the degree of
response per cell. Of note, cytometry experiments require
attention to resolve fluorescence from noise. Modern sys-
tems can have up to an 18-bit dynamic range, e.g., a
0–262,144 lower and upper value range. As a rule of
thumb, using a log-scale, specific signals should be placed
in the four-decade (104/10,000) to five-decade (105/
100,000) lower and upper end-linear value ranges to ensure
accurate and meaningful measurements.
Monitoring mitophagy receptor activity using LC3
immunoprecipitation
Finally, a critical tool in the analysis of LIR receptor activities
is the immunoprecipitation of tagged-LC3, and analysis of co-
precipitated protein by Western blot. Typically this is per-
formed using either of the following two approaches. Cell
lysates expressing a receptor of interest can be incubated with
purified GST-tagged LC3 proteins [64]. Alternatively, a tag-
ged LC3 (e.g., GFP-LC3), can be co-expressed with a receptor
of interest, and immunoprecipitated from the cell lysate [52]
(Fig. 8d). Using this latter approach, stable expression of
tagged-LC3B/GATE16 in combination with transient trans-
fection of the protein of interest is recommendable to provide
best reproducibility. In order to establish LIR-dependency of
an interaction with LC3, mutations can be introduced in the
putative LIR, e.g., tryptophan (W)-to-alanine (A) and/or
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leucine (L)-to-A, yielding core LIR-inactive mutants. Serine/
threonine(S/T)-to-glutamate (E) or aspartate (D) mutations
can be introduced to mimic the phosphorylated state, while
S/T-to-A mutation prevents phosphorylation [46, 52]. In
addition, basic residues at the W and L hydrophobic pockets of
LC3 proteins, e.g., LC3B lysine 49 [49], which interact with
acidic/phosphorylated residues preceding the receptor LIR
motif, can be mutated to further establish specificity of
receptor binding. Of note, mitophagy can be a slow process,
and cell line-dependently engaged 24–48 h following
transfection.
Concluding remarks
Mitochondrial dysfunction is implicated in nearly all dis-
ease, and recent discoveries suggest paths toward therapeutic
manipulation of mitophagy. To that end, the continued elu-
cidation of mechanisms underlying positive and negative
mitophagy regulation, as well as roles for mitophagy during
normal and stressed conditions will be instrumental in
developing treatment strategies. Among the important next
steps will be (1) the identification of the kinases and phos-
phatases that regulate LIR engagement of Bnip3 and Nix to
determine in vivo mitophagy significance; (2) the elucida-
tion of how morphology dynamics underlie mitochondrial
triage, prior to mitophagy engagement; and (3) an under-
standing of crosstalk between apoptosis and mitophagy
programs, i.e., how mitophagy behavior can regulate mito-
chondrial participation in programmed cell death. To these
ends, RNAi and drug screening using high-content mito-
phagy sensors will be increasingly important tools in
functional and mechanistic elucidation.
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